2011
DOI: 10.1016/j.ejphar.2011.03.001
|View full text |Cite
|
Sign up to set email alerts
|

Effects of specific prostanoid EP receptor agonists on cell proliferation and intracellular Ca2+ concentrations in human airway smooth muscle cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
21
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 28 publications
(22 citation statements)
references
References 49 publications
1
21
0
Order By: Relevance
“…There are no previous reports demonstrating functional expression of EP1 receptor in human ASM cells [18, 80, 88]. Indeed, either EP1 receptor agonist SC19220 or ONO-DI-004, did not affect proliferation of human ASM cells [18, 80].…”
Section: Pge2-mediated Modulation Of Asm Functionmentioning
confidence: 97%
See 2 more Smart Citations
“…There are no previous reports demonstrating functional expression of EP1 receptor in human ASM cells [18, 80, 88]. Indeed, either EP1 receptor agonist SC19220 or ONO-DI-004, did not affect proliferation of human ASM cells [18, 80].…”
Section: Pge2-mediated Modulation Of Asm Functionmentioning
confidence: 97%
“…Recent studies have explored the concept of EP receptor targeting as a means of improving the therapeutic potential of E prostanoids and the expression of mRNA for EP2, EP3, and EP4 receptors has been identified in human ASM cells [80, 82, 87]. Burgess et al demonstrated that ASM cells isolated from patients with asthma had more expression of EP3 and EP2 receptors than those from control subjects [82].…”
Section: Pge2-mediated Modulation Of Asm Functionmentioning
confidence: 99%
See 1 more Smart Citation
“…EP4 is highly expressed in airway smooth muscle cells, pulmonary fibroblasts, and smooth muscle cells of the pulmonary vein. In particular, together with the EP2 receptor, EP4 transcripts and proteins are abundantly expressed in human airway smooth muscle cells (Bradbury et al, 2005;Clarke et al, 2005;Mori et al, 2011;Benyahia et al, 2012). It is also known that EP4 activation causes potent relaxation in human and rat bronchial preparations (Lydford and McKechnie, 1994;Benyahia et al, 2012).…”
Section: +mentioning
confidence: 99%
“…Buckley et al (2011) reported that PGE 2 -induced relaxation of the airway was mediated through EP4 in humans and rats. Mori et al (2011) demonstrated that PGE 2 inhibited fetal bovine serum-induced proliferation of human airway smooth muscle cells via EP4 receptor activation. Taken together, these findings suggest that the EP4 receptor could potentially be a therapeutic target in treating pulmonary diseases such as asthma and chronic obstructive pulmonary disease.…”
Section: +mentioning
confidence: 99%